Combined Use of Bacteroides Fragilis and BCAAs on HBsAg Clearance

NCT07257562 · clinicaltrials.gov ↗

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: PegIFNα2b+Nucleoside analog
DRUG: PegIFNα2b+Nucleoside analog+Bacteroides fragilis+Branched-Chain Amino Acids

Sponsor

First Affiliated Hospital of Fujian Medical University